Skip to main content
Current Pharmacogenomics provides comprehensive overviews of all current research on pharmacogenomics and pharmacogenetics. All areas of the field from pre-clinical to clinical research are covered, including related areas such as genomics, proteomics, target discovery, bioinformatics and novel diagnostics. This international journal is peer-reviewed and publishes both mini- and full review articles.

The journal has become essential reading for all researchers and clinicians with interests in pharmacogenomics and pharmacogenetics.

Publisher: Bentham Science Publishers

More about this publication?
Volume 3, Number 4, 2005

Review article

Selection of Microbial T-Cell Epitopes for Immune-Diagnosis, Immune- Therapy and Vaccine Design
pp. 247-257(11)
Authors: Seghrouchni, Fouad; Berretta, Floriana; Amicosante, Massimo

Favourites:
ADD

Pharmacological Suppression of Premature Stop Mutations that Cause Genetic Diseases
pp. 259-269(11)
Authors: Keeling, K. M.; Bedwell, D. M.

Favourites:
ADD

Hypertensive Pharmacogenomics in African Americans
pp. 271-279(9)
Authors: Chapman, Arlene; Millhouse-Jones, Frieda; Lea, Janice; Rahbari, Frederic; Baranco-Pryor, Evelyn

Favourites:
ADD

Genomics and Proteomics of Nucleoside Transporters
pp. 281-287(7)
Authors: Reyes, German; Coe, Imogen R.

Favourites:
ADD

DNA Microarray-Based Gene Expression Profiling in Cancer: Aiding Cancer Diagnosis, Assessing Prognosis and Predicting Response to Therapy
pp. 289-304(16)
Authors: Duffy, Michael J.; Kelly, Zoe D.; Culhane, Aedín C.; O'Brien, Sallyann L.; Gallagher, William M.

Favourites:
ADD

A Candidate Pathway Strategy for Integration of Pharmacogenomic Components of Variability in Antipsychotic Treatment Outcomes: A Focus on Aripiprazole
pp. 305-317(13)
Authors: Reist, Christopher; Albers, Lawrence J.; Marder, Stephen R.; Williams-Jones, Bryn; Wu, Joseph C.; Mee, Steven; Shimoda, Kazutaka; Someya, Toshiyuki; Ozdemir, Vural

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content